• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶是肺部对新型隐球菌炎症反应所必需的。一种小鼠转基因模型。

Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

作者信息

Gyetko M R, Chen G H, McDonald R A, Goodman R, Huffnagle G B, Wilkinson C C, Fuller J A, Toews G B

机构信息

Department of Internal Medicine, Ann Arbor Veterans Affairs Medical Center and University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.

出版信息

J Clin Invest. 1996 Apr 15;97(8):1818-26. doi: 10.1172/JCI118611.

DOI:10.1172/JCI118611
PMID:8621764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC507249/
Abstract

Urokinase (uPA) is hypothesized to provide proteolytic activity enabling inflammatory cells to traverse tissues during recruitment, and it is implicated as a cytokine modulator. Definitive evaluation of these hypotheses in vivo has previously been impossible because uPA could not completely and irreversibly be eliminated. This limitation has been overcome through the development of uPA-deficient transgenic mice (uPA-/-). Using these mice, we evaluated the importance of uPA in the pulmonary inflammatory response to Cryptococcus neoformans (strain 52D). C. neoformans was inoculated into uPA-/- and control mice (uPA+/+), and cell recruitment to the lungs was quantitated. The number of CFU in lung, spleen and brain was determined to assess clearance, and survival curves were generated. By day 21 after inoculation, uPA-/- mice had markedly fewer pulmonary inflammatory (CD45+), CD4+, and CD11b/CD18+ cells compared with uPA+/+ controls (P<0.0007); pulmonary CFUs in the uPA-/- mice continued to increase, whereas CFUs diminished in uPA+/+ mice(P<0.005). In survival studies, only 3/19 uPA+/+ mice died, whereas 15/19 uPA-/- mice died (p<0.001). We have demonstrated that uPA is required for a pulmonary inflammatory response to C. neoformans. Lack of uPA results in inadequate cellular recruitment, uncontrolled infection, and death.

摘要

尿激酶(uPA)被认为具有蛋白水解活性,可使炎症细胞在募集过程中穿过组织,并且它被认为是一种细胞因子调节剂。由于无法完全且不可逆地消除uPA,以前无法在体内对这些假设进行明确评估。通过开发uPA缺陷型转基因小鼠(uPA-/-),这一限制已被克服。利用这些小鼠,我们评估了uPA在对新型隐球菌(52D菌株)的肺部炎症反应中的重要性。将新型隐球菌接种到uPA-/-小鼠和对照小鼠(uPA+/+)中,并对肺内细胞募集进行定量。测定肺、脾和脑中的菌落形成单位(CFU)数量以评估清除情况,并绘制生存曲线。接种后第21天,与uPA+/+对照相比,uPA-/-小鼠的肺部炎症(CD45+)、CD4+和CD11b/CD18+细胞明显减少(P<0.0007);uPA-/-小鼠肺部的CFU持续增加,而uPA+/+小鼠的CFU减少(P<0.005)。在生存研究中,19只uPA+/+小鼠中只有3只死亡,而19只uPA-/-小鼠中有15只死亡(P<0.001)。我们已经证明,uPA是对新型隐球菌肺部炎症反应所必需的。缺乏uPA会导致细胞募集不足、感染失控和死亡。

相似文献

1
Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.尿激酶是肺部对新型隐球菌炎症反应所必需的。一种小鼠转基因模型。
J Clin Invest. 1996 Apr 15;97(8):1818-26. doi: 10.1172/JCI118611.
2
Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection.尿激酶型纤溶酶原激活剂是对肺部新型隐球菌感染产生1型免疫反应所必需的。
J Immunol. 2002 Jan 15;168(2):801-9. doi: 10.4049/jimmunol.168.2.801.
3
Urokinase is required for T lymphocyte proliferation and activation in vitro.
J Lab Clin Med. 1999 Mar;133(3):274-88. doi: 10.1016/s0022-2143(99)90084-7.
4
Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans.实验性小鼠肺隐球菌病。两种新型隐球菌包膜菌株诱导的肺部炎症和淋巴细胞募集差异。
Lab Invest. 1994 Jul;71(1):113-26.
5
The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans.γ干扰素受体是对新型隐球菌产生保护性肺部炎症反应所必需的。
Infect Immun. 2005 Mar;73(3):1788-96. doi: 10.1128/IAI.73.3.1788-1796.2005.
6
Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.粒细胞巨噬细胞集落刺激因子在小鼠过敏性支气管肺真菌病期间宿主抵御新型隐球菌肺部感染中的作用
Am J Pathol. 2007 Mar;170(3):1028-40. doi: 10.2353/ajpath.2007.060595.
7
CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection.CCR2表达在肺部新型隐球菌感染过程中决定T1与T2极化。
J Immunol. 2000 Feb 15;164(4):2021-7. doi: 10.4049/jimmunol.164.4.2021.
8
IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6).在基因易感小鼠(C57BL/6)肺部新型隐球菌感染期间,嗜酸性粒细胞募集、晶体沉积和单核细胞募集需要白细胞介素-5。
J Immunol. 1998 Mar 1;160(5):2393-400.
9
Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.产生肿瘤坏死因子-α的传入相对于新型隐球菌保护性T细胞免疫的发展是必需的。
J Immunol. 1996 Nov 15;157(10):4529-36.
10
Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice.肺部新型隐球菌感染中细胞因子的早期产生可区分易感和抗性小鼠。
Am J Respir Cell Mol Biol. 1995 Oct;13(4):487-95. doi: 10.1165/ajrcmb.13.4.7546779.

引用本文的文献

1
The Protective Pathways Activated in Kidneys of αMUPA Transgenic Mice Following Ischemia\Reperfusion-Induced Acute Kidney Injury.αMUPA 转基因小鼠缺血/再灌注诱导急性肾损伤后肾脏中激活的保护途径。
Cells. 2023 Oct 20;12(20):2497. doi: 10.3390/cells12202497.
2
Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.尿激酶型纤溶酶原激活物表面受体通过阻止病毒粒子从细胞膜释放来限制 HIV-1 的复制。
Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2212991120. doi: 10.1073/pnas.2212991120. Epub 2023 Jan 13.
3
Prognostic Significance and Gene Co-Expression Network of and in Gliomas.胶质瘤中[具体基因名称]的预后意义及基因共表达网络
Front Oncol. 2022 Jan 11;11:602321. doi: 10.3389/fonc.2021.602321. eCollection 2021.
4
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.尿激酶型纤溶酶原激活剂(uPA)及其受体(uPAR)的多方面作用:诊断、预后及治疗应用
Front Oncol. 2018 Feb 12;8:24. doi: 10.3389/fonc.2018.00024. eCollection 2018.
5
Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis.多发性骨髓瘤中可溶性尿激酶型纤溶酶原激活物受体分析用于预测预后
Oncol Lett. 2015 Oct;10(4):2403-2409. doi: 10.3892/ol.2015.3613. Epub 2015 Aug 14.
6
Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.自杀未遂者血浆中可溶性尿激酶型纤溶酶原激活物受体(suPAR)水平升高。
PLoS One. 2015 Oct 9;10(10):e0140052. doi: 10.1371/journal.pone.0140052. eCollection 2015.
7
Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.精神分裂症患者可溶性尿激酶型纤溶酶原激活物受体水平
Schizophr Bull. 2015 May;41(3):764-71. doi: 10.1093/schbul/sbu118. Epub 2014 Aug 25.
8
Protein kinase C-δ mediates sepsis-induced activation of complement 5a and urokinase-type plasminogen activator signaling in macrophages.蛋白激酶 C-δ 介导线粒体 DNA 损伤诱导的巨噬细胞焦亡及其在动脉粥样硬化中的作用
Inflamm Res. 2014 Jul;63(7):581-9. doi: 10.1007/s00011-014-0729-1. Epub 2014 Mar 30.
9
Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.MUC1/sec,黏蛋白-1 的一种分泌形式,具有抗肿瘤和免疫增强活性的作用机制。
Immunol Res. 2013 Dec;57(1-3):70-80. doi: 10.1007/s12026-013-8451-6.
10
The intracellular life of Cryptococcus neoformans.新生隐球菌的细胞内生活。
Annu Rev Pathol. 2014;9:219-38. doi: 10.1146/annurev-pathol-012513-104653. Epub 2013 Sep 16.

本文引用的文献

1
Endogenously produced urokinase amplifies tumor necrosis factor-alpha secretion by THP-1 mononuclear phagocytes.
J Leukoc Biol. 1996 Feb;59(2):302-11. doi: 10.1002/jlb.59.2.302.
2
Interleukin 12: a potential link between nerve cells and the immune response in inflammatory disorders.白细胞介素12:炎症性疾病中神经细胞与免疫反应之间的潜在联系。
Mol Med. 1995 Sep;1(6):690-9.
3
Isolation and partial characterization of subpopulations of alveolar macrophages, granulocytes, and highly enriched interstitial macrophages from rat lung.大鼠肺中肺泡巨噬细胞、粒细胞和高度富集的间质巨噬细胞亚群的分离及部分特性分析
Am J Respir Cell Mol Biol. 1993 Apr;8(4):384-92. doi: 10.1165/ajrcmb/8.4.384.
4
Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1.
Am J Cardiol. 1993 Aug 15;72(5):397-401. doi: 10.1016/0002-9149(93)91129-6.
5
The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils.尿激酶型纤溶酶原激活剂及其受体在人中性粒细胞受到刺激时,会从两个不同的细胞内区室转位至质膜。
Blood. 1994 Feb 1;83(3):808-15.
6
Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.粒细胞-巨噬细胞集落刺激因子对大鼠肺泡巨噬细胞体外抗隐球菌活性的影响。
J Immunol. 1994 Jan 15;152(2):724-34.
7
Urokinase receptor. An activation antigen in human T lymphocytes.
J Immunol. 1994 Jan 15;152(2):505-16.
8
The urokinase receptor is required for human monocyte chemotaxis in vitro.体外人类单核细胞趋化性需要尿激酶受体。
J Clin Invest. 1994 Apr;93(4):1380-7. doi: 10.1172/JCI117114.
9
Physiological consequences of loss of plasminogen activator gene function in mice.小鼠纤溶酶原激活物基因功能缺失的生理后果。
Nature. 1994 Mar 31;368(6470):419-24. doi: 10.1038/368419a0.
10
Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites.尿激酶型纤溶酶原激活剂及纤溶酶原激活剂抑制剂1和2在人早期着床部位的免疫组织化学定位
Am J Obstet Gynecol. 1994 Feb;170(2):671-6. doi: 10.1016/s0002-9378(94)70246-2.